Vapendavir
3-ethoxy-6-[2-[1-(6-methylpyridazin-3-yl)piperidin-4-yl]ethoxy]-1,2-benzoxazole
Molecular Identity
Vapendavir
3-ethoxy-6-[2-[1-(6-methylpyridazin-3-yl)piperidin-4-yl]ethoxy]-1,2-benzoxazole
PubChem CID: 504457
2D Structure
Properties
C21H26N4O3
Molecular Formula
382.50
Molecular Weight
g/mol
382.2005
Exact Mass
Da
3.9
XLogP
Drug-like (Lipinski: < 5)
73.5
TPSA
Good oral absorption (< 140 A²)
0
H-Bond Donors
7
H-Bond Acceptors
475
Complexity
SMILES
Canonical SMILES
SMILES: CCOC1=NOC2=C1C=CC(=C2)OCCC3CCN(CC3)C4=NN=C(C=C4)CIsomeric SMILES
SMILES: CCOC1=NOC2=C1C=CC(=C2)OCCC3CCN(CC3)C4=NN=C(C=C4)CSynonyms(20)
Vapendavir439085-51-5BTA798Vapendavir [INN]UNII-Q8LVL5Z68HBTA-798DTXSID401959843-Ethoxy-6-(2-(1-(6-methylpyridazin-3-yl)piperidin-4-yl)ethoxy)-1,2-benzoxazole3-ethoxy-6-[2-[1-(6-methylpyridazin-3-yl)piperidin-4-yl]ethoxy]-1,2-benzoxazole3-Ethoxy-6-{2-[1-(6-Methylpyridazin-3-Yl)piperidin-4-Yl]ethoxy}-1,2-BenzoxazolevapendavirumRefChem:193714DTXCID801184753-Ethoxy-6-(2-(1-(6-methylpyridazin-3-yl)piperidin-4-yl)ethoxy)benzo[d]isoxazoleMFCD18633281
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Vapendavir
Loading drug network...